No Interaction Expected
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP)
Quality of Evidence:
Coadministration has not been studied but based on metabolism and elimination a clinically significant interaction is unlikely. Metabolism and elimination of levamisole has not been well characterized. Renal elimination of unchanged levamisole appears to be minimal, therefore interactions via competition for renal elimination pathways are not considered likely.
View all available interactions with
Emtricitabine/Tenofovir-DF (FTC/TDF, PrEP) by clicking